Heading 3001
2 subheadings
Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included. - Extracts of glands or other organs or of their secretions
1 tariff items
Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included. - Other
3 tariff items
Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included
Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)
Other This subheading includes intrinsic factor (dried purified extracts of pyloric mucous membrane of swine).
Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)
Other In addition to the glands and other organs mentioned in the HS Explanatory Note to heading 3001 , (A), these subheadings include the hypophysis, the suprarenal capsules and the thyroid gland.
Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)
Heparin and its salts See the HS Explanatory Note to heading 3001 , (C).
Source: eu_cn_en (EUR-Lex 02019XC0329(02)-20250113)
&&Section 10 of the Customs Tariff directs that classification of imported goods shall be determined in accordance with the General Rules for the Interpretation of the Harmonized System. Section 11 of the Customs Tariff states that in interpreting the headings and subheadings, regard shall be had to the World Customs Organization's (WCO) Explanatory Notes to the Harmonized Commodity...
Source: advance_ruling (C-2018-000131)